ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.1K |
295K |
33 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.6K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.6K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.6K |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.6K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Havenots
|
62 |
16K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Havenots
|
62 |
16K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Havenots
|
33 |
8.3K |
24 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.3K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Havenots
|
126 |
31K |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Havenots
|
196 |
36K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Havenots
|
196 |
36K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Havenots
|
58 |
14K |
23 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Havenots
|
58 |
14K |
15 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Havenots
|
77 |
19K |
7 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
77
|
19K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.1K |
295K |
22 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Havenots
|
58 |
14K |
12 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
14K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Havenots
|
311 |
77K |
34 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
311
|
77K
|
34
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Havenots
|
311 |
77K |
24 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
311
|
77K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.1K |
295K |
16 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Havenots
|
311 |
77K |
23 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
311
|
77K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.1K |
295K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Havenots
|
311 |
77K |
27 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
311
|
77K
|
27
|
|
ASX - By Stock
|
TZN |
Re:
Ann: Terramin secures US$6.68 million investment
|
|
Havenots
|
7 |
2.6K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Havenots
|
197 |
51K |
28 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
197
|
51K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Havenots
|
197 |
51K |
42 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
197
|
51K
|
42
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Havenots
|
197 |
51K |
26 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Havenots
|
197 |
51K |
34 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
51K
|
34
|
|
ASX - By Stock
|
TZN |
Re:
Ann: Terramin secures US$6.68 million investment
|
|
Havenots
|
7 |
2.6K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
Havenots
|
41 |
9.0K |
19 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
41
|
9.0K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Presentation and Non-Deal Roadshow
|
|
Havenots
|
11 |
3.5K |
15 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
11
|
3.5K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Havenots
|
323 |
74K |
30 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
323
|
74K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Havenots
|
323 |
74K |
16 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
74K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Havenots
|
323 |
74K |
15 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
74K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Ethics Committee Approval for Open-Label MND Extension Study
|
|
Havenots
|
23 |
6.9K |
41 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
23
|
6.9K
|
41
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
19 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
430
|
106K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
10 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
430
|
106K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
16 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
430
|
106K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
14 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
430
|
106K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
16 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
430
|
106K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
28 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
430
|
106K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
16 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
430
|
106K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
Havenots
|
98 |
23K |
14 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
98
|
23K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
Havenots
|
98 |
23K |
14 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
98
|
23K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
Havenots
|
98 |
23K |
15 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
98
|
23K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
14 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
430
|
106K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
17 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
430
|
106K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
27 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
430
|
106K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Havenots
|
430 |
106K |
28 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
430
|
106K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
Havenots
|
98 |
23K |
13 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
98
|
23K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
Havenots
|
61 |
16K |
13 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
61
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
Havenots
|
61 |
16K |
20 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
61
|
16K
|
20
|
|